Page last updated: 2024-08-17

methylene blue and Encephalopathy, Toxic

methylene blue has been researched along with Encephalopathy, Toxic in 21 studies

Research

Studies (21)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	11 (52.38)	29.6817
2010's	5 (23.81)	24.3611
2020's	5 (23.81)	2.80

Authors

Authors	Studies
Campino, GA; Chain, G; Kalia, M; Kestenbaum, K; Pappas, L; Sechser-Perl, A; Zaghloul, N	1
Han, J; Jian, X; Li, Y; Shi, L; Tao, Y	1
Cheung, JY; Haouzi, P; Haouzi-Judenherc, A; Langford, D; McCann, M; Santerre, M; Sariyer, I; Song, J; Tubbs, N; Wang, J; Zhang, XQ	1
El Okle, OS; Goma, AA; Tohamy, HG	1
Atay, AA; Demir, ÜF; Malbora, B; Sarbay, H; Yılmaz, G	1
Deianova, N; Hemelsoet, D; Honoré, PJ; Loret, G	1
Bärlund, M; Sunela, K	1
Hatfield Seung, A; Howell, JE; Nesbit, SA; Szabatura, AH	1
Bayliff, S; Bernard, PA; Hayes, D; McCabe, T	1
Chang, FW; Liu, YL; Tsai, SH; Yu, MH	1
Marshall, H; McQuary, A; Richards, A	1
Duong, CD; Good, DJ; Turner, AR	1
Bertolone, SJ; Jaffe, N; Raj, AB	1
Behar, C; Dufour, C; Grill, J; Hartmann, O; Motte, J; Munzer, M; Oberlin, O; Paci, A; Sabouraud, P	1
Patel, PN	1
Bumpous, JM; Chacko, CE; Fleming, M; Flynn, MB; Kartha, SS; Lentsch, EJ	1
Alici-Evcimen, Y; Breitbart, WS	1
Standiford, SB; Sweet, G	1
Basso, U; Brunello, A; Crivellari, G; Ghiotto, C; Marino, D; Monfardini, S; Rossi, E; Stefani, M	1
Beijnen, JH; de Kraker, J; Groen, HJ; Jansen, RL; Keizer, HJ; Kerbusch, T; Schellens, JH; van Putten, JW	1
Stewart, SL	1

Reviews

6 review(s) available for methylene blue and Encephalopathy, Toxic

Article	Year
A novel case of prolonged Ifosfamide encephalopathy and long-term treatment with methylene blue: a case report and review of literature. BMC pediatrics, 2022, 02-02, Volume: 22, Issue:1 Topics: Brain Diseases; Child; Female; Humans; Ifosfamide; Methylene Blue; Neurotoxicity Syndromes; Sleepiness	2022
[Treatment and prevention of iphosphamide-induced encephalopathy]. Duodecim; laaketieteellinen aikakauskirja, 2016, Volume: 132, Issue:4 Topics: Antiemetics; Antineoplastic Agents, Alkylating; Aprepitant; Drug Interactions; Enzyme Inhibitors; Humans; Ifosfamide; Methylene Blue; Morpholines; Neurotoxicity Syndromes	2016
Methylene blue for management of Ifosfamide-induced encephalopathy. The Annals of pharmacotherapy, 2006, Volume: 40, Issue:2 Topics: Humans; Ifosfamide; MEDLINE; Methylene Blue; Neurotoxicity Syndromes; Time Factors; Treatment Outcome	2006
Ifosfamide neuropsychiatric toxicity in patients with cancer. Psycho-oncology, 2007, Volume: 16, Issue:10 Topics: Adult; Antineoplastic Agents, Alkylating; Burkitt Lymphoma; Delusions; Enzyme Inhibitors; Female; Humans; Ifosfamide; Methylene Blue; Neurotoxicity Syndromes; Prognosis; Psychoses, Substance-Induced	2007
Methylene-blue-associated encephalopathy. Journal of the American College of Surgeons, 2007, Volume: 204, Issue:3 Topics: Enzyme Inhibitors; Humans; Infusions, Intravenous; Intraoperative Care; Methylene Blue; Neurotoxicity Syndromes; Parathyroidectomy; Prognosis	2007
Clinical pharmacokinetics and pharmacodynamics of ifosfamide and its metabolites. Clinical pharmacokinetics, 2001, Volume: 40, Issue:1 Topics: Animals; Antineoplastic Agents, Alkylating; Area Under Curve; Cyclophosphamide; Cytochrome P-450 Enzyme System; Enzyme Inhibitors; Fanconi Syndrome; Humans; Ifosfamide; Methylene Blue; Neurotoxicity Syndromes; Stereoisomerism	2001

Other Studies

15 other study(ies) available for methylene blue and Encephalopathy, Toxic

Article	Year
Toxic Encephalopathy and Methemoglobinemia after 5-Amino-2-(trifluoromethyl)pyridine Poisoning. International journal of environmental research and public health, 2022, 10-28, Volume: 19, Issue:21 Topics: Adult; Anemia, Hemolytic; Humans; Male; Methemoglobinemia; Methylene Blue; Neurotoxicity Syndromes; Poisoning; Pyridines	2022
Antidotal effects of methylene blue against cyanide neurological toxicity: in vivo and in vitro studies. Annals of the New York Academy of Sciences, 2020, Volume: 1479, Issue:1 Topics: Animals; Antidotes; Cell Line, Tumor; Dose-Response Relationship, Drug; Humans; Male; Methylene Blue; Neurons; Neurotoxicity Syndromes; Potassium Cyanide; Rats; Rats, Sprague-Dawley	2020
Protective effect of methylene blue against copper oxide nanoparticle-induced neurobehavioral toxicity. Behavioural brain research, 2021, 02-01, Volume: 398 Topics: Aldehyde Dehydrogenase, Mitochondrial; Animals; Apoptosis; Behavior, Animal; Brain; Copper; Disease Models, Animal; Enzyme Inhibitors; Glutamate Dehydrogenase; Male; Methylene Blue; Nanoparticles; Neurotoxicity Syndromes; Oxidative Stress; Rats	2021
Ifosfamide induced encephalopathy in a child with osteosarcoma. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners, 2021, Volume: 27, Issue:5 Topics: Adolescent; Antineoplastic Agents, Alkylating; Bone Neoplasms; Brain Diseases; Female; Humans; Ifosfamide; Methylene Blue; Neurotoxicity Syndromes; Osteosarcoma	2021
An easily overlooked cause of toxic encephalopathy: methylene blue in a patient on an SSRI. Acta neurologica Belgica, 2018, Volume: 118, Issue:1 Topics: Aged; Humans; Male; Methylene Blue; Monoamine Oxidase Inhibitors; Neurotoxicity Syndromes; Parathyroidectomy; Selective Serotonin Reuptake Inhibitors; Serotonin Syndrome; Sertraline	2018
Characterization of the occurrence of ifosfamide-induced neurotoxicity with concomitant aprepitant. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners, 2008, Volume: 14, Issue:3 Topics: Antidotes; Antiemetics; Antineoplastic Agents, Alkylating; Aprepitant; Delirium; Female; Humans; Ifosfamide; Kidney Function Tests; Liver Function Tests; Male; Methylene Blue; Middle Aged; Morpholines; Neuropsychological Tests; Neurotoxicity Syndromes; Retrospective Studies; Sarcoma	2008
Successful treatment of ifosfamide neurotoxicity with dexmedetomidine. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners, 2010, Volume: 16, Issue:4 Topics: Adrenergic alpha-2 Receptor Agonists; Antidotes; Antineoplastic Agents, Alkylating; Child, Preschool; Dexmedetomidine; Female; Humans; Hypnotics and Sedatives; Ifosfamide; Methylene Blue; Neurotoxicity Syndromes; Rhabdomyosarcoma; Treatment Outcome	2010
Ifosfamide-induced encephalopathy in patients with uterine sarcoma. Taiwanese journal of obstetrics & gynecology, 2010, Volume: 49, Issue:1 Topics: Aged; Antineoplastic Agents, Alkylating; Female; Humans; Ifosfamide; Methylene Blue; Middle Aged; Neoplasm Recurrence, Local; Neurotoxicity Syndromes; Sarcoma; Thiamine; Uterine Neoplasms; Vitamin B Complex	2010
Evaluation of methylene blue, thiamine, and/or albumin in the prevention of ifosfamide-related neurotoxicity. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners, 2011, Volume: 17, Issue:4 Topics: Adult; Drug Evaluation; Drug Therapy, Combination; Humans; Ifosfamide; Methylene Blue; Middle Aged; Neurotoxicity Syndromes; Retrospective Studies; Serum Albumin; Thiamine	2011
Methylene blue for the treatment and prophylaxis of ifosfamide-induced encephalopathy. Clinical oncology (Royal College of Radiologists (Great Britain)), 2003, Volume: 15, Issue:7 Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Female; Humans; Ifosfamide; Male; Methylene Blue; Neurotoxicity Syndromes	2003
Methylene blue reversal of ifosfamide-related encephalopathy. Journal of pediatric hematology/oncology, 2004, Volume: 26, Issue:2 Topics: Antineoplastic Agents, Alkylating; Bone Neoplasms; Child; Electroencephalography; Enzyme Inhibitors; Humans; Ifosfamide; Magnetic Resonance Imaging; Male; Methylene Blue; Neurotoxicity Syndromes; Osteosarcoma; Tomography, X-Ray Computed	2004
[Ifosfamide induced encephalopathy: 15 observations]. Archives de pediatrie : organe officiel de la Societe francaise de pediatrie, 2006, Volume: 13, Issue:2 Topics: Adolescent; Antineoplastic Agents, Alkylating; Child; Child, Preschool; Coma; Enzyme Inhibitors; Fatigue; Female; Humans; Ifosfamide; Male; Methylene Blue; Neoplasms; Neurotoxicity Syndromes; Retrospective Studies; Seizures	2006
Toxic metabolic encephalopathy after parathyroidectomy with methylene blue localization. Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery, 2006, Volume: 135, Issue:5 Topics: Female; Humans; Hyperparathyroidism; Male; Methylene Blue; Middle Aged; Neurotoxicity Syndromes; Parathyroidectomy; Retrospective Studies; Selective Serotonin Reuptake Inhibitors	2006
Ifosfamide-related encephalopathy in elderly patients : report of five cases and review of the literature. Drugs & aging, 2007, Volume: 24, Issue:11 Topics: Abdominal Neoplasms; Aged; Antidotes; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Confusion; Fatal Outcome; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Methylene Blue; Multiple Myeloma; Neurotoxicity Syndromes; Psychomotor Agitation; Risk Assessment; Sarcoma; Uterine Neoplasms	2007
Postchemotherapy confusion. Oncology nursing forum, 2001, Volume: 28, Issue:9 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Female; Humans; Ifosfamide; Mesna; Methylene Blue; Neurotoxicity Syndromes; Oncology Nursing; Osteosarcoma	2001